A prognostic factor (PF) index for overall survival in a HER2-negative endocrine-resistant metastatic breast cancer (MBC) population: Analysis from the ATHENA trial.
Antonio Llombart-Cussac
Consultant or Advisory Role - Roche
Honoraria - Roche
Xavier B. Pivot
Consultant or Advisory Role - Roche
Honoraria - Roche
Laura Biganzoli
No relevant relationships to disclose
Hernan Cortes-Funes
No relevant relationships to disclose
Kathleen I. Pritchard
No relevant relationships to disclose
Jean-Yves Pierga
Consultant or Advisory Role - Roche
Honoraria - Roche
Research Funding - Roche
Ian E. Smith
No relevant relationships to disclose
Christoph Thomssen
Honoraria - Roche
Other Remuneration - Roche
Gemma Palacios
Employment or Leadership Position - Roche
Stefanie Srock
Employment or Leadership Position - Roche
Stock Ownership - Roche
Miguel Sampayo
No relevant relationships to disclose
Javier Cortes
Consultant or Advisory Role - Celgene; Novartis; Roche
Honoraria - Celgene; Eisai; Novartis; Roche